Evaluating infection prevention strategies in out-patient dialysis units using agent-based modeling

PLoS ONE

Volumn 11, Issue 5, 2016, Pages

  Wares, Joanna R ^a   Lawson, Barry ^a   Shemin, Douglas ^b   D'Agata, Erika M C ^b  

^a UNIVERSITY OF RICHMOND   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMICROBIAL THERAPY; CONTAMINATION; HUMAN; INFECTION PREVENTION; MODEL; OUTPATIENT; RENAL REPLACEMENT THERAPY; WASTE MANAGEMENT; ADVERSE EFFECTS; ALGORITHM; BACTERIAL INFECTIONS; COMPUTER SIMULATION; CROSS INFECTION; DECONTAMINATION; EVALUATION STUDY; HAND WASHING; HEMODIALYSIS; HOSPITAL ADMISSION; MULTIDRUG RESISTANCE; PROCEDURES; RISK; THEORETICAL MODEL; TRANSMISSION; WOUND INFECTION;

ANTIINFECTIVE AGENT;

ALGORITHMS; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; COMPUTER SIMULATION; CROSS INFECTION; DECONTAMINATION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HAND HYGIENE; HUMANS; MODELS, THEORETICAL; PATIENT ADMISSION; RENAL DIALYSIS; RISK; WOUND INFECTION;

EID: 84991518618     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0153820     Document Type: Article

References (19)

1. Snyder GM, D'Agata EM. Novel antimicrobial-resistant bacteria among patients requiring chronic hemodialysis. Curr Opin Nephrol Hypertens. Mar 2012; 21(2):211-215. doi: 10.1097/MNH.0b013e328350089b PMID: 22240441
2. Pop-Vicas A, Strom J, Stanley K, D'Agata EM. Multidrug-resistant gram-negative bacteria among patients who require chronic hemodialysis. Clin J Am Soc Nephrol. May 2008; 3(3):752-758. doi: 10.2215/CJN.04651107 PMID: 18322047
3. D'Agata EM, Green WK, Schulman G, Li H, Tang YW, Schaffner W. Vancomycin-resistant enterococci among chronic hemodialysis patients: a prospective study of acquisition. Clin Infect Dis. Jan 2001; 32(1):23-29. PMID: 11112676
4. Schwaber MJ, Navon-Venezia S, Kaye KS, Ben-Ami R, Schwartz D, Carmeli Y. Clinical and economic impact of bacteremia with extended- spectrum-beta-lactamase-producing Enterobacteriaceae. Antimicrob Agents Chemother. Apr 2006; 50(4):1257-1262. PMID: 16569837
5. Savard P, Perl TM. Combating the spread of carbapenemases in Enterobacteriaceae: a battle that infection prevention should not lose. Clin Microbiol Infect. Sep 2014; 20(9):854-861. doi: 10.1111/1469-0691.12748 PMID: 24980472
6. Fox ER, Sweet BV, Jensen V. Drug shortages: a complex health care crisis. Mayo Clin Proc. Mar 2014; 89(3):361-373. doi: 10.1016/j.mayocp.2013.11.014 PMID: 24582195
7. Recommendations for preventing transmission of infections among chronic hemodialysis patients. MMWR Recomm Rep. Apr 27 2001; 50(RR-5):1-43.
8. Donskey CJ, Chowdhry TK, Hecker MT, Hoyen CK, Hanrahan JA, Hujer AM, et al. Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients. N Engl J Med. Dec 28 2000; 343(26):1925-1932. PMID: 11136263
9. D'Agata EM, Gautam S, Green WK, Tang YW. High rate of false-negative results of the rectal swab culture method in detection of gastrointestinal colonization with vancomycin-resistant enterococci. Clin Infect Dis. Jan 15 2002; 34(2):167-172. PMID: 11740703
10. Cheng VC, Li IW, Wu AK, Tang BSF, Ng KHL, To KKW, et al. Effect of antibiotics on the bacterial load of meticillin-resistant Staphylococcus aureus colonisation in anterior nares. J Hosp Infect. Sep 2008; 70 (1):27-34. doi: 10.1016/j.jhin.2008.05.019 PMID: 18632184
11. D'Agata EM, Horn MA, Ruan S, Webb GF, Wares JR. Efficacy of infection control interventions in reducing the spread of multidrug-resistant organisms in the hospital setting. PLoS One. 2012; 7(2):e30170. doi: 10.1371/journal.pone.0030170 PMID: 22363420
12. Lipsitch M, Samore MH. Antimicrobial use and antimicrobial resistance: a population perspective. Emerg Infect Dis. Apr 2002; 8(4):347-354. PMID: 11971765
13. Snyder GM, Patel PR, Kallen AJ, Strom JA, Tucker JK, D'Agata EM. Antimicrobial use in outpatient hemodialysis units. Infect Control Hosp Epidemiol. Apr 2013; 34(4):349-357. doi: 10.1086/669869 PMID: 23466906
14. U.S.Renal Data System UADRAoE-SRDitUSNIoH, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD. 2014.
15. Austin DJ, Bonten MJ, Weinstein RA, Slaughter S, Anderson RM. Vancomycin-resistant enterococci in intensive-care hospital settings: transmission dynamics, persistence, and the impact of infection control programs. Proc Natl Acad Sci U S A. Jun 8 1999; 96(12):6908-6913. PMID: 10359812
16. D'Agata EM, Horn MA, Webb GF. The impact of persistent gastrointestinal colonization on the transmission dynamics of vancomycin-resistant enterococci. J Infect Dis. Mar 15 2002; 185(6):766-773. PMID: 11920294
17. D'Agata EM. Antimicrobial use and stewardship programs among dialysis centers. Semin Dial. Jul-Aug 2013; 26(4):457-464. doi: 10.1111/sdi.12090 PMID: 23600755
18. Grabsch EA, Burrell LJ, Padiglione A, O'Keeffe JM, Ballard S, Grayson ML. Risk of environmental and healthcare worker contamination with vancomycin-resistant enterococci during outpatient procedures and hemodialysis. Infect Control Hosp Epidemiol. Mar 2006; 27(3):287-293. PMID: 16532417
19. Hotchkiss JR, Holley P, Crooke PS. Analyzing pathogen transmission in the dialysis unit: time for a schedule change? Clin J. Am. Soc. Nephrol. 2007; 2: 1176-1185. PMID: 17962421